Systemic phlebotropic drugs in pharmacotherapy of chronic venous insufficiency of the lower extremities
DOI:
https://doi.org/10.24959/nphj.15.2090Keywords:
chronic venous insufficiency, phlebotropic drugs, micronized purified flavonoid fractionAbstract
The modern aspects of pharmacotherapy of chronic venous insufficiency (CVI) of the lower extremities are presented in the article. Phlebotropic drugs are medications for basic pharmacotherapy of CVI. A common characteristic of pharmacodynamics of these drugs is the ability to increase the venous tone, and reduce severity of specific symptoms and syndromes of CVI. The efficiency of the most widespread venotonic drugs has been analyzed. The largest number of preclinical and clinical research among all groups of veno-active drugs has been devoted to the study of Micronized Purified Flavonoid Fraction (MPFF). It has been determined that the therapeutic effect of MPFF is higher compared to the therapeutic effect of non-micronised Diosmin. An important feature of the action of MPFF is a rapid onset of the venotonic effect, the effect is shown already from the first hour after administration and lasts during the day. This action is successfully complemented by improved rheological properties of the blood, reduction in blood viscosity, stimulation of the drainage function of lymphatic vessels. Treatment should be given by courses, which duration depends on disease severity, and is for 2-3 months, but not less than twice a year. The continuous therapeutic scheme can be used in the case of refractory forms of CVI. MPFF is characterized by a high clinical efficacy, high bioavailability and safety. It does not cause serious adverse reactions, well tolerated and can be used as a drug of the first choice.References
Богачев В.Ю., Голованова О.В., Кузнецов А.Н. и др. // Ангиол. и сосудистая хирургия. – 2013. – Т. 19, №1. – С. 73-81.
Засорин А.А., Макарова Н.П., Нарицина В.В. // Флебол. – 2011. – №1. – С. 22-24.
Кириенко А.И., Богачев В.Ю., Золотухин И.А. и др. // Consilium medicum. Хирургия. – 2007. – №1. – С. 45-49.
Литвиненко О.О., Коноваленко В.Ф., Бугайцов С.Г. и др. // Укр. тер. журн. – 2013. – №2. – С. 116-123.
Олійник М.В., Приходько В.Ю. // Ліки України. – 2010. – №3 (12). – С. 24-29.
Савельев В.С., Гологорский В.А., Кириенко А.И. и др. – М.: Медицина, 2001. – 664 с.
Усенко О.Ю., Нікульніков П.І., Чернуха Л.М. та ін. Клініко-практ. рекоменд. – К., 2014. – 120 с.
Янушко В.А., Небылицин Ю.С., Климчук И.П. // Новости медицины. – 2013. – №6. – С. 70-73.
Agus G.B. // Phlebolymphol. – 2013. – Vol. 20 (2). – P. 101-111.
Allaert F.A. // Int. Angiol. – 2012. – Vol. 31 (4). – P. 310-315.
Belczak S.Q., Sincos I.R., Campos W. et al. // Phlebol. – 2014. – Vol. 29 (7). – P. 454-460.
Burak F., Gunduz Т., Simsek M. et al. // Phlebolymphol. – 2009. – Vol. 16(3). – P. 290-294.
Cazaubon M., Bailly C., Ducros E. S. et al. // Angiol. – 2011. – Vol. 63(2). – P. 2-48.
Cohen J.M., Akl E.A., Kahn S.R. // Chest. – 2012. – Vol. 141 (2). – P. 308-320.
Fotiadis E., Kenanidis E., Samoladas E. et al. // Arch. Orthop. Trauma Surg. – 2011. – Vol. 131 (3). – P. 389-392.
Gillet J.L. // Medicographia. – 2011. – Vol. 33. – P. 285-291.
Gloviczki P., Comerota A.J., Dalsing M.C. et al. // J. Vase. Surg. – 2011. – Vol. 53 (Suppl. 5). – P. 2S-48S.
Marinovic K.S., Lupi D. // Acta Dermatovenerol. Croat. – 2012. – Vol. 20 (3). – P. 197-200.
Mowatt-Larssen E., Shortell C. // Vasc. Surg. – 2012. – Vol. 23. – P. 118-122.
Nicolaides A. // Phlebolymphol. – 2009. – Vol. 16 (4). – P. 340-346.
Pannier F., Rabe E. // Phlebol. – 2012. – Vol. 27. – P. 23-26.
Pereira A.J. // Rev. Port. Cir. Cardiotorac. Vase – 2010. – Vol. 15 (1). – P. 51-56.
Perrin M., Ramelet A.A. // Eur. J. Vasc. Endovasc. Surg. – 2011. – Vol. 41 (1). – P. 117-125.
Rabe E., Guex J.J., Puskas A. et al. // Int. Angiol. – 2012. – Vol. 31 (2). – P. 105-115.
Word R. // Surg. Clin. N. Am. – 2010. – Vol. 90. – P. 1195-1214.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
